Why Hemp ~ Cannabis Products?
From my personal experience the use of Hemp~Cannabis products have change my life ten fold for the better. Don’t take my word for it do your own research, to help you we placed a few articles here for you to begin your journey of knowledge. Own your own health and wellness, don’t be swayed by outside influences with their own agendas.
Inflammatory and Neuropathic Pain
Cannabinoids have been shown to reduce the intensity of pain, including inflammatory pain, neuropathic pain, and cancer pain.[1,2,3] Cannabinoids reduce spasticity and the pain associated with muscle spasm. Beyond decreasing the intensity of pain, many patients report that cannabis changes the nature of the pain, making it more bearable and less distracting. In certain situations, cannabinoids can increase the intensity of acute pain.
Cannabinoids have neuroprotective effects, protecting the nerves from acute injuries like head trauma and stroke, and from conditions that cause chronic nerve injury, such as multiple sclerosis and Alzheimer’s disease. They have anticonvulsant effects, and in some circumstances, antipsychotic effects. For example, CBD has been shown to have antipsychotic effects at high doses in human clinical studies. See CBD curriculum, chapter 2, lesson 8 for more details.
Cannabinoids also affect our consciousness via the nervous system. Depending on the strain or preparation, cannabinoids can be awakening or sedating. Cannabinoids can slow reaction time and cause other changes in sensory perception. Many patients report positive mood, relaxation, laughter, social comfort, time distortion, and the intensification of ordinary experiences (e.g. eating, sex, listening to music) after using cannabis. Cannabis can cause both a dissociative effect (awareness detaching from the physical body and one’s environment) and, conversely, an integrating effect (greater awareness of self and environment).
 Lynch, M. E., and Mark A. Ware. “Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials.” Journal of neuroimmune pharmacology 10.2 (2015): 293-301.
 Noyes, R., et al. “The analgesic properties of delta-9-tetrahydrocannabinol.” Clin Pharmacol Ther 18.1 (1975): 84-89.
 Portenoy, Russell K., et al. “Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.” The Journal of Pain 13.5 (2012): 438-449.
 Koppel, Barbara S., et al. “Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology.” Neurology 82.17 (2014): 1556-1563.
 Mechoulam, Raphael, David Panikashvili, and Esther Shohami. “Cannabinoids and brain injury: therapeutic implications.” Trends in molecular medicine 8.2 (2002): 58-61.
 Ramaekers, Johannes G., et al. “Dose related risk of motor vehicle crashes after cannabis use.” Drug and alcohol dependence 73.2 (2004): 109-119.
Anti Viral Benefits of Hemp / Cannabis
CORVALLIS, Ore. – Hemp compounds identified by Oregon State University research via a chemical screening technique invented at OSU show the ability to prevent the virus that causes COVID-19 from entering human cells.
Findings of the study led by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute, were published today in the Journal of Natural Products.
Hemp, known scientifically as Cannabis sativa, is a source of fiber, food and animal feed, and multiple hemp extracts and compounds are added to cosmetics, body lotions, dietary supplements and food, van Breemen said.
Van Breemen and collaborators, including scientists at Oregon Health & Science University, found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people.
Cannabis and Alzheimer’s
According to WHO, Alzheimer’s disease (AD) is portrayed by a dynamic decrease in psychological function. Promotion of AD is generously expanded among individuals matured 65 years or more, with a dynamic decrease in memory, thinking, language, and learning capacity. The promotion of AD ought to be separated from an ordinary age-related decrease in cognitive function, which is progressively slow and connected with less inability. Illness frequently begins with mild symptoms and finishes with serious brain damage . According to Alzheimer’s association, 1 in 10 people of age above 65 years have Alzheimer’s dementia, as of 2019, and risk of it increases with age . One of the main factors in Alzheimer’s progression is the accumulation of beta-amyloid proteins in the patient. A randomized, double-blind clinical study at the University of Toronto suggested that nabilone, a synthetic cannabinoid, was effective in treating agitation and other behavioral symptoms of Alzheimer’s . Medical cannabis oil containing THC as an add-on leads to a significant decrease in neurobehavioral symptoms such as delusions, agitation/aggression, irritability, apathy, sleep, and caregiver distress. Medical cannabis can help prevent or delay the onset of Alzheimer’s and slow the disease’s progression . Furthermore, THC competitively represses the compound acetylcholinesterase and additionally prevents acetylcholinesterase-actuated amyloid β-peptide aggregation, the key neurotic marker of Alzheimer’s disease.
Cannabis and Sleep Disorders
In addition to helping you fall asleep faster, marijuana may alter your sleep architecture9, a term that describes how long you spend in the different sleep stages10. Short-term cannabis use appears to increase the time you spend in deep sleep, the stage that helps you wake up feeling refreshed. However, THC decreases the amount of time you spend in rapid eye movement (REM) sleep, when you spend more time dreaming, processing emotions, and cementing new memories.
Decreasing REM sleep may have some benefits for people with PTSD, since nightmares11 are a common and disturbing symptom. A study on women with PTSD found that those with more severe PTSD symptoms and poor sleep were more likely to use cannabis to help them cope. One study found that synthetic forms of cannabis significantly decreased nightmares, or stopped them completely, for people with PTSD. Some participants in this study also reported experiencing better overall sleep quality and fewer daytime flashbacks.
Cannabis and Menopause
The risk of depression and anxiety is higherTrusted Source around the time of menopause, and this may be due to changing hormones, other menopause symptoms, or both.
Studies in animals, including a 2014 reviewTrusted Source of the relevant research in mice, have found that CBD can reduce the effects of depression and anxiety.
However, as the authors of a 2020 reviewTrusted Source caution, there has only been very limited related research in humans.
They note that only a few case studies exist in which individual people with a history of depression have reported improvements after taking CBD.
They also point to text that is part of the packaging of FDA-approved CBD, called Epidiolex, which lists depression and suicidal ideation as possible side effects.
Many people report difficulty getting quality sleep during menopause, and this issue can have a significant impact on daily life.
According to the 2020 reviewTrusted Source mentioned above, endocannabinoids play a role in the sleep-wake cycle. This suggests that CBD can affect sleep.
The researchers highlight the few, limited studies on CBD and sleep in humans. The results of these suggest that higher doses of CBD can have a sedating effect.
It is possible, therefore, that CBD oil may help treat sleep disturbances relating to menopause — but there is no strong evidence.
People begin to lose bone mass after menopause. Osteoporosis affects 1 in 4 femalesTrusted Source aged 65 and over.
Having low bone density can increase the risk of fractures, so it is crucial to receive treatment.
A 2008 study in animals found that CBD interacts with a cannabinoid receptor that may play a role in bone density loss. CBD may, therefore, be able to reduce the rate of bone density loss that can occur during menopause.
However, this has not been demonstrated in humans — no research has shown that CBD improves bone density loss related to menopause.